Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
465 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 22 (5%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 381 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
51 (10%) |
|
Overdue reports |
12 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLANZAPINE | 15MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198789 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-01-20 | 2020-03-04 | 103707 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-03-10 | 2020-10-21 | 108338 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-08-14 | 2018-09-05 | 58073 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
| LOSARTAN | 25MG | TABLET | Resolved | 2018-11-21 | 2019-07-26 | 67318 |
| LOSARTAN | 25MG | TABLET | Resolved | 2019-07-25 | 2021-05-06 | 89940 |
| LOSARTAN | 25MG | TABLET | Actual shortage | 2021-09-13 | 2021-09-14 | 145531 |
| LOSARTAN | 50MG | TABLET | Resolved | 2018-11-21 | 2019-02-20 | 67324 |
| LOSARTAN | 50MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82938 |
| LOSARTAN | 50MG | TABLET | Actual shortage | 2021-09-13 | 2024-05-28 | 145534 |
| LOSARTAN | 100MG | TABLET | Resolved | 2018-11-21 | 2019-02-26 | 67327 |
| LOSARTAN | 100MG | TABLET | Resolved | 2019-05-01 | 2021-05-06 | 82935 |
| LOSARTAN | 100MG | TABLET | Resolved | 2021-09-13 | 2024-03-02 | 145528 |
| LOSARTAN | 100MG | TABLET | Actual shortage | 2021-09-20 | 2024-04-23 | 145888 |
| CANDESARTAN | 4MG | TABLET | Resolved | 2017-04-10 | 2017-05-10 | 6263 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4933 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4939 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |
| RAMIPRIL-HCTZ | 25.0MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3026 |
| RAMIPRIL-HCTZ | 12.5MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3029 |
| RAMIPRIL-HCTZ | 25.0MG 5.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3032 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4924 |
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| ROPINIROLE | 5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4945 |